more_reports

Streetwise Articles



Drone Co.'s Purchase Set To Transform Pipeline Monitoring
Source: Streetwise Reports  (11/21/22)
Volatus Aerospace Corp.'s acquisition of an Alberta aviation company puts it in a strong position to change the way oil and gas companies monitor their pipelines. More >


FDA Awards Breakthrough Therapy Status for AMD Drug
Source: Streetwise Reports  (11/21/22)
Iveric Bio Inc. shares traded 25% higher Friday after the company reported that the U.S. FDA has granted breakthrough therapy designation for its avacincaptad pegol for use in the treatment of geographic atrophy secondary to age-related macular degeneration. More >


Adrian Day

Diversification Pays off for Franco Once Again
Source: Adrian Day  (11/21/22)
Expert Adrian Day reviews quarterly financials from several resource companies. Most are doing well, though costs are rising. But given recent rallies in stock prices, Day suggests, for the most part, holding rather than buying more. More >


Michael Ballanger

Expert Says 'No Mas' to Hawkish Fed
Source: Michael Ballanger  (11/21/22)
In light of the controversy with FTX Corp., expert Michael Ballanger shares his opinion on current news coverage and the state of the gold market and U.S. dollar to tell you his view on the precious metals and whether he believes we are headed toward a bear market rally. More >


Ron Struthers

Winter Is About To Wake up the Natural Gas Price
Source: Ron Struthers  (11/21/22)
An unusually warm October has helped natural gas inventories, but gas prices don't seem to believe it. Oil has seen three days of heavy selling volume ending with a hammer candle stick Monday. Birchcliff, Callon, and Earthstone should benefit. More >


Rare Earths Co. Finishes Drilling Campaign, Looks Forward to PFS
Source: Streetwise Reports  (11/18/22)
Defense Metals Corp. is looking toward the preliminary feasibility study for its Wicheeda rare earth element deposit in British Columbia. More >


New Drill Results From Idaho Point to Gold Resource Growth
Source: Geordie Mark  (11/18/22)
The explorer's ongoing exploration results at this project continue to be encouraging ahead of a mineral resource update expected next year, noted a Haywood Securities report. More >


Drilling Proves 'Connector Zone' Exists at Gold Asset
Source: Jacques Wortman  (11/18/22)
The owner of this Quebec project will include these exploration results in the upcoming definitive feasibility study, noted a Laurentian Bank Securities report. More >


Pharma Co. Won't See Bump in Sales From New COVID Drug
Source: Dr. Andre Uddin  (11/18/22)
The U.S. Food and Drug Administration Advisory Panel denied the approval of this therapeutic for patients hospitalized with severe SARS-CoV-2, yet it is still a Buy, noted a Research Capital Corp. report. More >


Canadian Base Metals Co. Gains Two New Assets
Source: Adam Schatzker  (11/17/22)
The company takeover just closed, and consequently, an NI 43-101 report from the acquirer is expected soon, noted a Research Capital Corp. report. More >


Copper Small Cap With Two Development-Stage Projects 'Undervalued'
Source: Streetwise Reports  (11/17/22)
World Copper's projects in Arizona and Chile are in the near-term development stage. More >


Alberta Co. Boosts Natural Gas and Oil Sales by 67% in Q3
Source: Streetwise Reports  (11/17/22)
Shares of Alvopetro Energy Ltd. traded 13% higher yesterday after the company reported record Q3/22 sales, raised its quarterly dividend by 50%, and announced plans for a robust NCIB share buyback program. More >


Pivoting Junior Signs Agreement for Nevada Lithium Project
Source: Streetwise Reports  (11/17/22)
Rover Metals Corp. has signed the definitive agreement to option a 100% ownership interest in a Nevada lithium project that puts it closer to its goal of pivoting from gold to lithium and critical elements. More >


Biopharma Co. Hopes To Turn US$30M Into US$2B
Source: Streetwise Reports  (11/17/22)
CytomX Therapeutics Inc. shares traded 32% higher after the company reported it has formed a strategic research collaboration with Regeneron Pharmaceuticals Inc. to develop next-generation bispecific immunotherapies to treat multiple cancer tumor types. More >


Target Price Raised on Counterdrone Tech Co.
Source: Daniel Laing  (11/16/22)
The Australian firm warrants this change given its recent track record in growing revenue, noted a Bell Potter report. More >


Green Energy Co. Sells Some of Its Okla. Oil Property
Source: Streetwise Reports  (11/16/22)
Jericho Energy Ventures Inc., which is making the move to green energy, is selling some of its undeveloped acreage in the STACK oil region of Oklahoma. More >


Biotech Co.'s Shares Rise 38% on Ph. 1/2 Wet AMD Trial Data
Source: Streetwise Reports  (11/16/22)
4D Molecular Therapeutics Inc. shares traded 38.5% higher yesterday after the company reported interim data from its Phase 1/2 clinical trial of Intravitreal 4D-150 for use in the treatment of wet age-related macular degeneration. More >


Healthcare Co.'s New Protocol 3.5X More Efficient Addiction Treatment
Source: Streetwise Reports  (11/14/22)
This U.K. healthcare company revealed a compound that's 3.5x more effective in treating alcohol use disorder than the industry standard. Now, expansion is on the horizon. More >


Lithium Triangle Explorer 'A Smart Money Play'
Source: Streetwise Reports  (11/14/22)
New extraction technology is a game-changer for Spey Resources, which just signed a lithium offtake letter of intent. More >


Copper Project Returns 'Very Good' Drill Results
Source: Adam Schatzker  (11/14/22)
This data set "highlights the potential of the southern starter pit and its ability to provide higher grade material for longer in the early years of the mine," noted a Research Capital Corp. report. More >


New Drill Results Expand Deposit, Leading to Buy Rating
Source: Dr. Geordie Mark  (11/14/22)
These early results of 2022 drilling at this Golden Triangle property highlight the presence of high silver grades and potential for future resource growth, noted a Haywood Securities report. More >


Firm to Gain Mining Royalty on Project in Ecuador for $50M
Source: Kerry Smith  (11/14/22)
The acquisition is a 0.6% net smelter return royalty on production that is estimated to start at this copper-gold property in late 2029, noted a Haywood Securities report. More >


Michael Ballanger

The Narcotic Effect of the Reflexive Rebound
Source: Michael Ballanger  (11/14/22)
Expert Michael Ballanger of GGM Advisory Inc. reviews the newest dubbed "investment guru," the outlook of the precious metals sector, and the current state of the stock market to tell you where he believes we are all headed. More >


Copper Co. Rated 'Strong Buy for All Timeframes'
Source: Clive Maund  (11/14/22)
Since copper has just broken out of a multi-month Cup & Handle base, expert Clive Maund reviews four charts of a company he believes you should set your sights on. More >


UK Co. Buys NARCAN® Nasal Spray Maker
Source: Streetwise Reports  (11/14/22)
Opiant Pharmaceuticals Inc. shares traded 111% higher after the company reported it entered into a definitive agreement to be acquired by Indivior Plc. for US$20.00 per share in cash. Opiant shareholders will also receive contingent value rights that are worth up to an additional US$8.00/share if certain product sales milestones are met. More >


Showing Results: 3751 to 3775 of 25183 Prev Next

Get Our Streetwise Reports Newsletter Free and be the first to know!

A valid email address is required to subscribe